MYGN
MYRIAD GENETICS INCMarquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Glenview Capital | Q4 2019 | 27Q | $25 | $4.30 | -82% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $28 | $4.30 | -84% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $28 | $4.30 | -84% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $28 | $4.30 | -84% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $28 | $4.30 | -84% |
| Point72 Asset Management | Q3 2024(8Q snapshot) | 7Q | $28 | $4.30 | -84% |
| Renaissance Technologies | Q4 2024(8Q snapshot) | 6Q | $16 | $4.30 | -73% |
| Two Sigma Investments | Q2 2025(8Q snapshot) | 4Q | $4.11 | $4.30 | +5% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Maverick Capital | Q3 2016 | Q2 2017 | → $22 | +4% |
| Tiger Global | Q1 2014 | Q3 2015 | → $33 | +5% |
| Viking Global Investors | Q3 2014 | Q4 2014 | → $33 | -9% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at MYRIAD GENETICS INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 9, 2026 — the most recent Form 4 on file — not from today.
- Form 40001824720-26-000004Jun 9, 2026
- Form 40001628280-26-041258Jun 5, 2026
- Form 40001788981-26-000002Jun 5, 2026
- Form 40002024613-26-000002Jun 5, 2026
- Form 40001471518-26-000004Jun 5, 2026
- Form 40001379372-26-000002Jun 5, 2026
- Form 40001740730-26-000002Jun 5, 2026
- Form 40001237253-26-000004Jun 5, 2026
- Form 40001824720-26-000002Jun 5, 2026
- Form 40002134322-26-000004Jun 2, 2026
- Form 40001237253-26-000002May 14, 2026
- Form 40002065630-26-000004May 4, 2026
- Form 40001517026-26-000008Apr 15, 2026
- Form 40001922964-26-000010Apr 15, 2026
- Form 40001922964-26-000008Mar 23, 2026
Fundamentals
XBRL · MYRIAD GENETICS INCAnnual figures sourced directly from MYRIAD GENETICS INC's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for MYRIAD GENETICS INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventJun 4, 2026
- 10-QQuarterly reportMay 6, 2026
- 8-KMaterial eventMay 5, 2026
- DEF 14AProxy statementApr 14, 2026
- S-3Registration (shelf)Feb 24, 2026
- 10-KAnnual reportFeb 24, 2026
- 8-KMaterial eventFeb 23, 2026
- 8-KMaterial eventJan 12, 2026
- 10-QQuarterly reportNov 4, 2025
- 8-K/AMaterial event (amended)Nov 4, 2025
- 8-KMaterial eventNov 3, 2025
- 8-KMaterial eventOct 7, 2025
- 8-KMaterial eventOct 3, 2025
- 8-KMaterial eventAug 18, 2025
- 10-QQuarterly reportAug 6, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Two Sigma Investments | Q2 2025 | open | $4.11 | $3.65 | -11% |
| Renaissance Technologies | Q4 2024 | open | $16 | $3.65 | -77% |
| Citadel Advisors | Q3 2024 | open | $28 | $3.65 | -87% |
| D.E. Shaw | Q3 2024 | open | $28 | $3.65 | -87% |
| AQR Capital Management | Q3 2024 | open | $28 | $3.65 | -87% |
| Millennium Management | Q3 2024 | open | $28 | $3.65 | -87% |
| Point72 Asset Management | Q3 2024 | open | $28 | $3.65 | -87% |
| Glenview Capital | Q4 2019 | open | $25 | $3.65 | -85% |
| Maverick Capital | Q3 2016 | Q2 2017 | $21 | $22 | +4% |
| Viking Global Investors | Q3 2014 | Q4 2014 | $36 | $33 | -9% |
| Tiger Global | Q1 2014 | Q3 2015 | $31 | $33 | +5% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.